Pharma Journalist -

Iovance Biotherapeutics and MaSTherCell announced that the two companies have entered into a new three-year Manufacturing Services Agreement. MaSTherCell will manufacture TIL for…
Read More...

Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering. New commercial scale equipment for blending, tableting…
Read More...

IDT Biologika announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the United States Department of…
Read More...

Foundation Medicine announced a strategic collaboration with Novartis allowing the development of companion diagnostic (CDx) tests for the Novartis portfolio of targeted oncology and…
Read More...

Biogen and Samsung Bioepis announced the European launch of IMRALDI (adalimumab), a biosimilar referencing HUMIRA. Starting today, IMRALDI will begin launching in major markets across…
Read More...

Kala Pharmaceuticals announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for KPI-121 0.25%, a topical product candidate…
Read More...

Novan announced that the Company has established a strategic alliance with Orion Corporation, a Finnish full-scale pharmaceutical company with broad experience in manufacturing. The…
Read More...

MeiraGTx Holdings Plc announced that it has entered into a research collaboration and evaluation agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen…
Read More...

AstraZeneca and Merck announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) for LYNPARZA for the treatment of pancreatic cancer. LYNPARZA is…
Read More...

Aclaris Therapeutics announced it has entered into a definitive asset purchase agreement with Allergan Sales, LLC to acquire worldwide rights to RHOFADE (oxymetazoline hydrochloride)…
Read More...